Resource centre

Main menu

293 results

Cancer research

Workflow
Workflow overview: tumour-normal sequencing
July 21 2025
Workflow
Workflow overview: single-cell transcriptomics
February 24 2025
Workflow
Workflow overview: Hereditary Cancer Panel
January 20 2026
Workflow
Workflow overview: human variant calling
April 29 2025
Workflow
Workflow overview: bulk transcriptomics
July 28 2025
Publication
The whole is greater than the sum of its parts: long-read sequencing for solving clinical problems in haematology
January 23 2024
Video
Whole-genome insights: nanopore sequencing in neuropathology
May 19 2025
Video
Resolving complex genomic structures and regulation patterns in cervical cancer
April 11 2023
Video
Parent-of-origin-aware genomic analysis infers segregation of pathogenic variants
June 26 2023
Video
Nanopore sequencing: insights from neonatal intensive care to cancer
November 15 2023
Video
Detecting, classifying, and monitoring CNS tumors with nanopore sequencing
July 14 2023
Knowledge exchange
Adaptive sampling explained: the future of flexible target enrichment
September 23 2025
Case study
Wastewater sequencing — an early warning system for infectious disease outbreaks
November 10 2022
Publication
Wakhan: reconstruction of chromosome-scale copy number profiles of tumour genomes with long-read sequencing
December 15 2025
Video
Cancer WGS on the PromethION
September 8 2021
Publication
Validation of HPV genotyping by Oxford Nanopore sequencing in FFPE tissues and ThinPrep anal and gynaecological samples
June 4 2025
Video
Using ultra-long-read Oxford Nanopore sequencing to detect complex structural variants in leukaemia
May 19 2025
Video
Unraveling gene expression patterns in pediatric germ cell tumors: a nanopore sequencing approach
September 17 2024
Poster
Understanding genetic variation in cancer using targeted long-read sequencing
September 26 2019
Case study
Case study: understanding the drivers of oncogenesis
September 14 2023

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

Workflow overview: tumour-normal sequencing

Workflow overview: single-cell transcriptomics

Workflow overview: Hereditary Cancer Panel

Workflow overview: human variant calling

Workflow overview: bulk transcriptomics

The whole is greater than the sum of its parts: long-read sequencing for solving clinical problems in haematology

Whole-genome insights: nanopore sequencing in neuropathology

Resolving complex genomic structures and regulation patterns in cervical cancer

Parent-of-origin-aware genomic analysis infers segregation of pathogenic variants

Nanopore sequencing: insights from neonatal intensive care to cancer

Detecting, classifying, and monitoring CNS tumors with nanopore sequencing

Adaptive sampling explained: the future of flexible target enrichment

Wastewater sequencing — an early warning system for infectious disease outbreaks

Wakhan: reconstruction of chromosome-scale copy number profiles of tumour genomes with long-read sequencing

Cancer WGS on the PromethION

Validation of HPV genotyping by Oxford Nanopore sequencing in FFPE tissues and ThinPrep anal and gynaecological samples

Using ultra-long-read Oxford Nanopore sequencing to detect complex structural variants in leukaemia

Unraveling gene expression patterns in pediatric germ cell tumors: a nanopore sequencing approach

Understanding genetic variation in cancer using targeted long-read sequencing

Case study: understanding the drivers of oncogenesis

shared.filter

Products

Research areas

Techniques